Active, Not Recruiting
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
NCT06451159
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- University of California, San Francisco, Multiple Sclerosis Center San Francisco, California, United States